144 related articles for article (PubMed ID: 30177847)
1. Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls.
Behravan H; Hartikainen JM; Tengström M; Pylkäs K; Winqvist R; Kosma VM; Mannermaa A
Sci Rep; 2018 Sep; 8(1):13149. PubMed ID: 30177847
[TBL] [Abstract][Full Text] [Related]
2. Predicting breast cancer risk using interacting genetic and demographic factors and machine learning.
Behravan H; Hartikainen JM; Tengström M; Kosma VM; Mannermaa A
Sci Rep; 2020 Jul; 10(1):11044. PubMed ID: 32632202
[TBL] [Abstract][Full Text] [Related]
3. Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility.
Lonjou C; Eon-Marchais S; Truong T; Dondon MG; Karimi M; Jiao Y; Damiola F; Barjhoux L; Le Gal D; Beauvallet J; Mebirouk N; Cavaciuti E; Chiesa J; Floquet A; Audebert-Bellanger S; Giraud S; Frebourg T; Limacher JM; Gladieff L; Mortemousque I; Dreyfus H; Lejeune-Dumoulin S; Lasset C; Venat-Bouvet L; Bignon YJ; Pujol P; Maugard CM; Luporsi E; Bonadona V; Noguès C; Berthet P; Delnatte C; Gesta P; Lortholary A; Faivre L; Buecher B; Caron O; Gauthier-Villars M; Coupier I; Mazoyer S; Monraz LC; Kondratova M; Kuperstein I; Guénel P; Barillot E; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Int J Cancer; 2021 Apr; 148(8):1895-1909. PubMed ID: 33368296
[TBL] [Abstract][Full Text] [Related]
4. Discovery of breast cancer risk genes and establishment of a prediction model based on estrogen metabolism regulation.
Zhao F; Hao Z; Zhong Y; Xu Y; Guo M; Zhang B; Yin X; Li Y; Zhou X
BMC Cancer; 2021 Feb; 21(1):194. PubMed ID: 33632172
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.
Li Y; Li Y; Wedrén S; Li G; Charn TH; Desai KV; Bonnard C; Czene K; Humphreys K; Darabi H; Einarsdóttir K; Heikkinen T; Aittomäki K; Blomqvist C; Chia KS; Nevanlinna H; Hall P; Liu ET; Liu J
Breast Cancer Res; 2011 Jan; 13(1):R10. PubMed ID: 21269472
[TBL] [Abstract][Full Text] [Related]
6. Trans-ethnic predicted expression genome-wide association analysis identifies a gene for estrogen receptor-negative breast cancer.
Gao G; Pierce BL; Olopade OI; Im HK; Huo D
PLoS Genet; 2017 Sep; 13(9):e1006727. PubMed ID: 28957356
[TBL] [Abstract][Full Text] [Related]
7. Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
Shaker OG; Senousy MA
Clin Breast Cancer; 2019 Feb; 19(1):e220-e238. PubMed ID: 30309792
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
9. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
J Genet; 2020; 99():. PubMed ID: 32366738
[TBL] [Abstract][Full Text] [Related]
10. Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors.
Rudolph A; Milne RL; Truong T; Knight JA; Seibold P; Flesch-Janys D; Behrens S; Eilber U; Bolla MK; Wang Q; Dennis J; Dunning AM; Shah M; Munday HR; Darabi H; Eriksson M; Brand JS; Olson J; Vachon CM; Hallberg E; Castelao JE; Carracedo A; Torres M; Li J; Humphreys K; Cordina-Duverger E; Menegaux F; Flyger H; Nordestgaard BG; Nielsen SF; Yesilyurt BT; Floris G; Leunen K; Engelhardt EG; Broeks A; Rutgers EJ; Glendon G; Mulligan AM; Cross S; Reed M; Gonzalez-Neira A; Arias Perez JI; Provenzano E; Apicella C; Southey MC; Spurdle A; ; ; Häberle L; Beckmann MW; Ekici AB; Dieffenbach AK; Arndt V; Stegmaier C; McLean C; Baglietto L; Chanock SJ; Lissowska J; Sherman ME; Brüning T; Hamann U; Ko YD; Orr N; Schoemaker M; Ashworth A; Kosma VM; Kataja V; Hartikainen JM; Mannermaa A; Swerdlow A; ; Giles GG; Brenner H; Fasching PA; Chenevix-Trench G; Hopper J; Benítez J; Cox A; Andrulis IL; Lambrechts D; Gago-Dominguez M; Couch F; Czene K; Bojesen SE; Easton DF; Schmidt MK; Guénel P; Hall P; Pharoah PD; Garcia-Closas M; Chang-Claude J
Int J Cancer; 2015 Mar; 136(6):E685-96. PubMed ID: 25227710
[TBL] [Abstract][Full Text] [Related]
11. Using machine learning to identify gene interaction networks associated with breast cancer.
Liu L; Zhai W; Wang F; Yu L; Zhou F; Xiang Y; Huang S; Zheng C; Yuan Z; He Y; Yu Z; Ji J
BMC Cancer; 2022 Oct; 22(1):1070. PubMed ID: 36253742
[TBL] [Abstract][Full Text] [Related]
12. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
[TBL] [Abstract][Full Text] [Related]
13. Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.
Rudolph A; Hein R; Lindström S; Beckmann L; Behrens S; Liu J; Aschard H; Bolla MK; Wang J; Truong T; Cordina-Duverger E; Menegaux F; Brüning T; Harth V; ; Severi G; Baglietto L; Southey M; Chanock SJ; Lissowska J; Figueroa JD; Eriksson M; Humpreys K; Darabi H; Olson JE; Stevens KN; Vachon CM; Knight JA; Glendon G; Mulligan AM; Ashworth A; Orr N; Schoemaker M; Webb PM; ; ; Guénel P; Brauch H; Giles G; García-Closas M; Czene K; Chenevix-Trench G; Couch FJ; Andrulis IL; Swerdlow A; Hunter DJ; Flesch-Janys D; Easton DF; Hall P; Nevanlinna H; Kraft P; Chang-Claude J;
Endocr Relat Cancer; 2013 Dec; 20(6):875-87. PubMed ID: 24080446
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
[TBL] [Abstract][Full Text] [Related]
15. A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer.
Campa D; Barrdahl M; Tsilidis KK; Severi G; Diver WR; Siddiq A; Chanock S; Hoover RN; Ziegler RG; Berg CD; Buys SS; Haiman CA; Henderson BE; Schumacher FR; Le Marchand L; Flesch-Janys D; Lindström S; Hunter DJ; Hankinson SE; Willett WC; Kraft P; Cox DG; Khaw KT; Tjønneland A; Dossus L; Trichopoulos D; Panico S; van Gils CH; Weiderpass E; Barricarte A; Sund M; Gaudet MM; Giles G; Southey M; Baglietto L; Chang-Claude J; Kaaks R; Canzian F
PLoS One; 2014; 9(2):e85955. PubMed ID: 24523857
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer genome-wide association studies: there is strength in numbers.
Fanale D; Amodeo V; Corsini LR; Rizzo S; Bazan V; Russo A
Oncogene; 2012 Apr; 31(17):2121-8. PubMed ID: 21996731
[TBL] [Abstract][Full Text] [Related]
17. Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm.
Reinbolt RE; Sonis S; Timmers CD; Fernández-Martínez JL; Cernea A; de Andrés-Galiana EJ; Hashemi S; Miller K; Pilarski R; Lustberg MB
Cancer Med; 2018 Jan; 7(1):240-253. PubMed ID: 29168353
[TBL] [Abstract][Full Text] [Related]
18. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
19. Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive Breast Cancer Patients.
Allahloubi NMA; Zekri AN; Ragab M; Mohanad M; Ahmed OS; Eid S; Ghareeb M; Gouda I; Bahnassy AA
Biochem Genet; 2022 Dec; 60(6):1963-1985. PubMed ID: 35182276
[TBL] [Abstract][Full Text] [Related]
20. A genome-wide association scan on estrogen receptor-negative breast cancer.
Li J; Humphreys K; Darabi H; Rosin G; Hannelius U; Heikkinen T; Aittomäki K; Blomqvist C; Pharoah PD; Dunning AM; Ahmed S; Hooning MJ; Hollestelle A; Oldenburg RA; Alfredsson L; Palotie A; Peltonen-Palotie L; Irwanto A; Low HQ; Teoh GH; Thalamuthu A; Kere J; D'Amato M; Easton DF; Nevanlinna H; Liu J; Czene K; Hall P
Breast Cancer Res; 2010; 12(6):R93. PubMed ID: 21062454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
